688613 奥精医疗
已收盘 02-06 15:00:01
资讯
新帖
简况
每周股票复盘:奥精医疗(688613)预计2025年净利1353万
证券之星 · 02-01
每周股票复盘:奥精医疗(688613)预计2025年净利1353万
股市必读:奥精医疗(688613)预计2025年全年营业收入2.24亿元
证券之星 · 01-29
股市必读:奥精医疗(688613)预计2025年全年营业收入2.24亿元
奥精医疗最新公告:预计2025年净利润1353.17万元左右同比扭亏为盈
证券之星 · 01-28
奥精医疗最新公告:预计2025年净利润1353.17万元左右同比扭亏为盈
每周股票复盘:奥精医疗(688613)股东减持135.55万股,持股比例降至5.19%
证券之星 · 01-25
每周股票复盘:奥精医疗(688613)股东减持135.55万股,持股比例降至5.19%
奥精医疗(688613)披露持股5%以上股东减持计划完成暨减持结果公告,1月20日股价下跌1.69%
证券之星 · 01-20
奥精医疗(688613)披露持股5%以上股东减持计划完成暨减持结果公告,1月20日股价下跌1.69%
每周股票复盘:奥精医疗(688613)董事及高管提前终止减持计划
证券之星 · 01-11
每周股票复盘:奥精医疗(688613)董事及高管提前终止减持计划
奥精医疗(688613)披露关于变更签字注册会计师的公告,01月07日股价上涨0.05%
证券之星 · 01-07
奥精医疗(688613)披露关于变更签字注册会计师的公告,01月07日股价上涨0.05%
每周股票复盘:奥精医疗(688613)高管减持1.8万股,股价下跌1.41%
证券之星 · 01-02
每周股票复盘:奥精医疗(688613)高管减持1.8万股,股价下跌1.41%
奥精医疗:12月30日至12月31日高管宋天喜、王玲减持股份合计1.8万股
中金财经 · 2025-12-31
奥精医疗:12月30日至12月31日高管宋天喜、王玲减持股份合计1.8万股
奥精医疗:12月29日高管王玲减持股份合计2500股
证券之星 · 2025-12-30
奥精医疗:12月29日高管王玲减持股份合计2500股
每周股票复盘:奥精医疗(688613)股东减持30.0万股触及1%刻度
证券之星 · 2025-12-28
每周股票复盘:奥精医疗(688613)股东减持30.0万股触及1%刻度
12月26日奥精医疗发布公告,股东减持30万股
证券之星 · 2025-12-26
12月26日奥精医疗发布公告,股东减持30万股
奥精医疗:12月24日高管王玲减持股份合计312股
证券之星 · 2025-12-25
奥精医疗:12月24日高管王玲减持股份合计312股
奥精医疗(688613)披露关于审计机构变更项目质量控制复核人的公告,12月23日股价下跌4.31%
证券之星 · 2025-12-23
奥精医疗(688613)披露关于审计机构变更项目质量控制复核人的公告,12月23日股价下跌4.31%
奥精医疗:12月22日高管仇志烨、宋天喜减持股份合计6.5万股
证券之星 · 2025-12-22
奥精医疗:12月22日高管仇志烨、宋天喜减持股份合计6.5万股
奥精医疗:12月19日高管仇志烨、宋天喜、王玲减持股份合计5.75万股
证券之星 · 2025-12-19
奥精医疗:12月19日高管仇志烨、宋天喜、王玲减持股份合计5.75万股
12月17日奥精医疗发生1笔大宗交易 成交金额288.87万元
证券之星 · 2025-12-17
12月17日奥精医疗发生1笔大宗交易 成交金额288.87万元
奥精医疗:12月11日至12月15日高管田国峰减持股份合计3.75万股
证券之星 · 2025-12-15
奥精医疗:12月11日至12月15日高管田国峰减持股份合计3.75万股
奥精医疗:12月10日高管仇志烨、宋天喜减持股份合计2万股
证券之星 · 2025-12-10
奥精医疗:12月10日高管仇志烨、宋天喜减持股份合计2万股
奥精医疗:12月9日高管仇志烨、宋天喜、王玲减持股份合计1.7万股
证券之星 · 2025-12-09
奥精医疗:12月9日高管仇志烨、宋天喜、王玲减持股份合计1.7万股
加载更多
公司概况
公司名称:
奥精医疗科技股份有限公司
所属行业:
专用设备制造业
上市日期:
2021-05-21
主营业务:
奥精医疗科技股份有限公司的主营业务是高端生物医用材料及相关医疗器械产品的研发、生产、销售及服务。公司的主要产品是BONGOLD、单牙抗旋基台、骼金、齿贝、颅瑞、口腔种植体。公司先后承担了国家“863计划”重大项目课题、“十一五”和“十二五”国家科技支撑计划、“十三五”和“十四五”国家重点研发计划、山东省重点研发计划(重大科技创新工程)项目、北京市科技计划等国家和省部级重大研发项目,并荣获国家级和北京市专精特新“小巨人”企业、国家高新技术企业、北京市企业技术中心、北京生物医药产业跨越发展工程(G20工程)-创新引领企业、北京市海淀园“海帆企业”、北京市级企业科技研究开发机构等荣誉和资质,并在北京和山东两地均拥有院士工作站。公司的矿化胶原人工骨修复产品被中国科技部评为“国际原创类创新医疗器械”,材料的相关基础研究和产业化工作曾荣获国家自然科学奖二等奖、国家技术发明奖二等奖,产品的临床应用和治疗体系研究荣获北京市科学技术进步奖二等奖和中华医学会医学科学技术奖一等奖,产品的创新研究荣获第48届日内瓦国际发明展金奖。报告期内,由解放军总医院第四医学中心骨科医学部王征教授团队牵头、奥精医疗科技股份有限公司深度参与的国家级科研项目“脊柱脊髓战创伤救治技术创新与应用”,凭借其突破性成果和重大军事应用价值荣获中央军委颁发的军事科学技术进步奖一等奖。
发行价格:
16.43
{"stockData":{"symbol":"688613","market":"SH","secType":"STK","nameCN":"奥精医疗","latestPrice":22.26,"timestamp":1770361201000,"preClose":22.19,"halted":0,"volume":2258329,"delay":0,"changeRate":0.0032,"floatShares":137000000,"shares":137000000,"eps":-0.0264,"marketStatus":"已收盘","change":0.07,"latestTime":"02-06 15:00:01","open":22.35,"high":22.72,"low":21.97,"amount":50610100,"amplitude":0.0338,"askPrice":22.26,"askSize":134,"bidPrice":22.25,"bidSize":54,"shortable":0,"etf":0,"ttmEps":-0.0264,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770600600000},"marketStatusCode":5,"adr":0,"adjPreClose":22.19,"symbolType":"stock_kcb","openAndCloseTimeList":[[1770341400000,1770348600000],[1770354000000,1770361200000]],"highLimit":24.41,"lowLimit":19.97,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":137008584,"isCdr":false,"pbRate":2.13,"roa":"--","roe":"0.98%","epsLYR":-0.09,"committee":-0.360269,"marketValue":3050000000,"turnoverRate":0.0165,"status":0,"afterMarket":{"amount":0,"volume":0,"close":22.26,"buyVolume":0,"sellVolume":0,"time":1770363237558,"indexStatus":"已收盘 02-06 15:30:00","preClose":22.19},"floatMarketCap":3050000000},"requestUrl":"/m/hq/s/688613","defaultTab":"news","newsList":[{"id":"2608776150","title":"每周股票复盘:奥精医疗(688613)预计2025年净利1353万","url":"https://stock-news.laohu8.com/highlight/detail?id=2608776150","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608776150?lang=zh_cn&edition=full","pubTime":"2026-02-01 02:53","pubTimestamp":1769885587,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘,奥精医疗报收于22.79元,较上周的24.28元下跌6.14%。本周,奥精医疗1月27日盘中最高价报24.9元。本周关注点业绩披露要点:奥精医疗预计2025年归属净利润1353.17万元,实现扭亏为盈。奥精医疗发布业绩预告,预计2025年全年扣非后净利润亏损约51.47万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100000888.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688613"],"gpt_icon":0},{"id":"2607974957","title":"股市必读:奥精医疗(688613)预计2025年全年营业收入2.24亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607974957","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607974957?lang=zh_cn&edition=full","pubTime":"2026-01-29 01:37","pubTimestamp":1769621830,"startTime":"0","endTime":"0","summary":"截至2026年1月28日收盘,奥精医疗报收于23.96元,下跌2.24%,换手率3.19%,成交量4.37万手,成交额1.06亿元。来自业绩披露要点:奥精医疗预计2025年全年扣非后净利润亏损约51.47万元,归属净利润盈利约1353.17万元,实现扭亏为盈。来自公司公告汇总:奥精医疗预计2025年营业收入约为2.24亿元,同比增长8.48%,受益于骨科人工骨集采带来的市场机遇及公司强化生产保障和营销策略。奥精医疗发布业绩预告,预计2025年全年营业收入2.24亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900000989.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688613"],"gpt_icon":0},{"id":"2606794193","title":"奥精医疗最新公告:预计2025年净利润1353.17万元左右同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2606794193","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606794193?lang=zh_cn&edition=full","pubTime":"2026-01-28 17:50","pubTimestamp":1769593835,"startTime":"0","endTime":"0","summary":"奥精医疗(688613.SH)公告称,预计2025年度实现归母净利润1353.17万元左右,同比实现扭亏为盈。2025全年公司实现营业收入2.24亿元左右,同比增长8.48%左右。报告期内,骨科人工骨集采为公司提供了临床使用继续上量、进一步扩大市场份额的机会。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012800030964.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688613"],"gpt_icon":0},{"id":"2606690232","title":"每周股票复盘:奥精医疗(688613)股东减持135.55万股,持股比例降至5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606690232","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606690232?lang=zh_cn&edition=full","pubTime":"2026-01-25 02:36","pubTimestamp":1769279773,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘,奥精医疗报收于24.28元,较上周的23.09元上涨5.15%。本周,奥精医疗1月23日盘中最高价报24.59元。减持前奇伦天佑持有公司8,468,000股,占总股本6.18%。减持完成后,奇伦天佑持股数量为7,112,485股,持股比例降至5.19%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500000793.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688613","BK0251"],"gpt_icon":0},{"id":"2604196267","title":"奥精医疗(688613)披露持股5%以上股东减持计划完成暨减持结果公告,1月20日股价下跌1.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604196267","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604196267?lang=zh_cn&edition=full","pubTime":"2026-01-20 17:32","pubTimestamp":1768901564,"startTime":"0","endTime":"0","summary":"公告显示,公司持股5%以上股东北京奇伦天佑创业投资有限公司本次减持计划已实施完毕。减持前,奇伦天佑持有公司8,468,000股,占总股本6.18%。自2025年9月24日披露减持计划后,奇伦天佑于2025年10月23日至2026年1月19日期间通过集中竞价方式累计减持1,355,515股,占公司总股本1%,减持价格区间为21.00至23.85元/股,减持总金额30,672,196.73元。减持完成后,奇伦天佑持股数量为7,112,485股,持股比例降至5.19%。本次减持计划已按期完成,未通过大宗交易减持,也未提前终止。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000028016.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688613","BK0251"],"gpt_icon":0},{"id":"2602535407","title":"每周股票复盘:奥精医疗(688613)董事及高管提前终止减持计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2602535407","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602535407?lang=zh_cn&edition=full","pubTime":"2026-01-11 03:11","pubTimestamp":1768072266,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘,奥精医疗报收于23.11元,较上周的20.31元上涨13.79%。本周关注点公司公告汇总:董事及高级管理人员提前终止减持计划,已完成原定减持数量。公司公告汇总奥精医疗科技股份有限公司董事及高级管理人员仇志烨、王玲、宋天喜、田国峰因自身资金需求,于2025年11月11日披露减持计划,原定减持期间为2025年12月3日至2026年3月3日。基于市场及个人情况,上述人员决定提前终止本次减持计划。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100000846.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688613","BK0251"],"gpt_icon":0},{"id":"2601801700","title":"奥精医疗(688613)披露关于变更签字注册会计师的公告,01月07日股价上涨0.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601801700","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601801700?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:46","pubTimestamp":1767797175,"startTime":"0","endTime":"0","summary":"截至2026年1月7日收盘,奥精医疗报收于21.6元,较前一交易日上涨0.05%,最新总市值为29.59亿元。公司近日发布公告称,原聘任立信会计师事务所为公司2025年度财务审计及内部控制审计机构,原签字注册会计师为常明、周末。因立信内部工作调整,现变更为田伟接替常明担任签字注册会计师,变更后由田伟、周末继续完成审计工作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700039268.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688613"],"gpt_icon":0},{"id":"2600039432","title":"每周股票复盘:奥精医疗(688613)高管减持1.8万股,股价下跌1.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600039432","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600039432?lang=zh_cn&edition=full","pubTime":"2026-01-02 04:22","pubTimestamp":1767298930,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘,奥精医疗报收于20.79元,较上周的20.18元上涨3.02%。12月22日盘中最低价报20.19元。奥精医疗当前最新总市值27.83亿元,在医疗器械板块市值排名113/127,在两市A股市值排名4669/5181。本周关注点股本股东变化:董事宋天喜、高管王玲合计减持1.8万股,占总股本0.0131%。交易信息汇总:12月31日公司股价下跌1.41%,收盘报20.31元。2025年12月29日,高级管理人员王玲减持公司股份2500股,占公司总股本的0.0018%。变动期间公司股价下跌0.91%,当日收盘报20.6元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200001293.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688613"],"gpt_icon":0},{"id":"2595774977","title":"奥精医疗:12月30日至12月31日高管宋天喜、王玲减持股份合计1.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2595774977","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595774977?lang=zh_cn&edition=full","pubTime":"2025-12-31 21:26","pubTimestamp":1767187570,"startTime":"0","endTime":"0","summary":"证券之星消息,根据12月31日市场公开信息、上市公司公告及交易所披露数据整理,奥精医疗最新董监高及相关人员股份变动情况:2025年12月30日至2025年12月31日公司董事宋天喜、高级管理人员王玲共减持公司股份1.8万股,占公司总股本为0.0131%。变动期间公司股价下跌1.41%,12月31日当日收盘报20.31元。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202512/31/20251231107961.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202512/31/20251231107961.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251231/31909014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["688613","BK0251"],"gpt_icon":0},{"id":"2595908794","title":"奥精医疗:12月29日高管王玲减持股份合计2500股","url":"https://stock-news.laohu8.com/highlight/detail?id=2595908794","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595908794?lang=zh_cn&edition=full","pubTime":"2025-12-30 20:03","pubTimestamp":1767096193,"startTime":"0","endTime":"0","summary":"证券之星消息,根据12月30日市场公开信息、上市公司公告及交易所披露数据整理,奥精医疗最新董监高及相关人员股份变动情况:2025年12月29日公司高级管理人员王玲共减持公司股份2500.0股,占公司总股本为0.0018%。变动期间公司股价下跌0.91%,12月29日当日收盘报20.6元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000038373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688613","BK0251"],"gpt_icon":0},{"id":"2594442252","title":"每周股票复盘:奥精医疗(688613)股东减持30.0万股触及1%刻度","url":"https://stock-news.laohu8.com/highlight/detail?id=2594442252","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594442252?lang=zh_cn&edition=full","pubTime":"2025-12-28 03:10","pubTimestamp":1766862621,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘,奥精医疗报收于20.79元,较上周的20.18元上涨3.02%。本周关注点股本股东变化:股东北京奇伦天佑创业投资有限公司减持30.0万股,持股比例由6.18%降至5.96%,权益变动触及1%刻度。股本股东变化股东增减持12月26日奥精医疗发布公告,股东北京奇伦天佑创业投资有限公司于2025年12月22日至12月25日合计减持30.0万股,占公司总股本的0.219%,持股比例从6.18%下降至5.96%。高管增减持2025年12月24日,公司高级管理人员王玲减持312股,占总股本0.0002%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800000662.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688613","BK0251"],"gpt_icon":0},{"id":"2594299689","title":"12月26日奥精医疗发布公告,股东减持30万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2594299689","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594299689?lang=zh_cn&edition=full","pubTime":"2025-12-26 21:01","pubTimestamp":1766754081,"startTime":"0","endTime":"0","summary":"证券之星消息,12月26日奥精医疗发布公告《奥精医疗:关于持股5%以上股东权益变动触及1%刻度的提示性公告》,其股东北京奇伦天佑创业投资有限公司于2025年12月22日至2025年12月25日间合计减持30.0万股,占公司目前总股本的0.219%,变动期间该股股价上涨5.75%,截止12月25日收盘报21.34元。股东增减持详情见下表:根据奥精医疗2025年三季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600033587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688613"],"gpt_icon":0},{"id":"2594726231","title":"奥精医疗:12月24日高管王玲减持股份合计312股","url":"https://stock-news.laohu8.com/highlight/detail?id=2594726231","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594726231?lang=zh_cn&edition=full","pubTime":"2025-12-25 20:02","pubTimestamp":1766664169,"startTime":"0","endTime":"0","summary":"证券之星消息,根据12月25日市场公开信息、上市公司公告及交易所披露数据整理,奥精医疗最新董监高及相关人员股份变动情况:2025年12月24日公司高级管理人员王玲共减持公司股份312.0股,占公司总股本为0.0002%。变动期间公司股价上涨0.76%,12月24日当日收盘报21.25元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500031359.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688613"],"gpt_icon":0},{"id":"2593757496","title":"奥精医疗(688613)披露关于审计机构变更项目质量控制复核人的公告,12月23日股价下跌4.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593757496","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593757496?lang=zh_cn&edition=full","pubTime":"2025-12-23 17:58","pubTimestamp":1766483887,"startTime":"0","endTime":"0","summary":"截至2025年12月23日收盘,奥精医疗报收于21.09元,较前一交易日下跌4.31%,最新总市值为28.9亿元。该股当日开盘21.91元,最高21.91元,最低20.92元,成交额达1.18亿元,换手率为4.04%。近日,奥精医疗科技股份有限公司发布公告,因立信会计师事务所内部工作调整,将公司2025年度审计项目质量控制复核人由单大信变更为王芳。王芳为中国注册会计师,自2012年起在立信执业,2025年开始为公司提供审计服务,近三年未因执业行为受过处罚,符合独立性要求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300029272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688613"],"gpt_icon":0},{"id":"2593748281","title":"奥精医疗:12月22日高管仇志烨、宋天喜减持股份合计6.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2593748281","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593748281?lang=zh_cn&edition=full","pubTime":"2025-12-22 20:02","pubTimestamp":1766404936,"startTime":"0","endTime":"0","summary":"证券之星消息,根据12月22日市场公开信息、上市公司公告及交易所披露数据整理,奥精医疗最新董监高及相关人员股份变动情况:2025年12月22日公司董事仇志烨、董事宋天喜共减持公司股份6.5万股,占公司总股本为0.0474%。变动期间公司股价上涨9.22%,12月22日当日收盘报22.04元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200029323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688613","BK0251"],"gpt_icon":0},{"id":"2592697521","title":"奥精医疗:12月19日高管仇志烨、宋天喜、王玲减持股份合计5.75万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2592697521","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592697521?lang=zh_cn&edition=full","pubTime":"2025-12-19 20:02","pubTimestamp":1766145729,"startTime":"0","endTime":"0","summary":"证券之星消息,根据12月19日市场公开信息、上市公司公告及交易所披露数据整理,奥精医疗最新董监高及相关人员股份变动情况:2025年12月19日公司董事仇志烨、董事宋天喜、高级管理人员王玲共减持公司股份5.75万股,占公司总股本为0.0419%。变动期间公司股价上涨2.54%,12月19日当日收盘报20.18元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121900034266.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688613","BK0251"],"gpt_icon":0},{"id":"2592425995","title":"12月17日奥精医疗发生1笔大宗交易 成交金额288.87万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592425995","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592425995?lang=zh_cn&edition=full","pubTime":"2025-12-17 17:50","pubTimestamp":1765965017,"startTime":"0","endTime":"0","summary":"证券之星消息,12月17日奥精医疗发生大宗交易,交易数据如下:大宗交易成交价格19.26元,相对当日收盘价折价1.98%,成交15万股,成交金额288.87万元,买方营业部为国海证券股份有限公司山东分公司,卖方营业部为华泰证券股份有限公司南京中山东路华泰证券大厦证券营业部。近三个月该股共发生5笔大宗交易,合计成交6600.0手,折价成交5笔。截至2025年12月17日收盘,奥精医疗报收于19.65元,下跌1.16%,换手率3.28%,成交量4.49万手,成交额8705.2万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121700028359.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688613"],"gpt_icon":0},{"id":"2591645227","title":"奥精医疗:12月11日至12月15日高管田国峰减持股份合计3.75万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2591645227","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591645227?lang=zh_cn&edition=full","pubTime":"2025-12-15 20:01","pubTimestamp":1765800110,"startTime":"0","endTime":"0","summary":"证券之星消息,根据12月15日市场公开信息、上市公司公告及交易所披露数据整理,奥精医疗最新董监高及相关人员股份变动情况:2025年12月11日至2025年12月15日公司董事田国峰共减持公司股份3.75万股,占公司总股本为0.0273%。变动期间公司股价下跌0.1%,12月15日当日收盘报20.02元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500029978.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688613","BK0251"],"gpt_icon":0},{"id":"2590720581","title":"奥精医疗:12月10日高管仇志烨、宋天喜减持股份合计2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2590720581","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590720581?lang=zh_cn&edition=full","pubTime":"2025-12-10 20:02","pubTimestamp":1765368131,"startTime":"0","endTime":"0","summary":"证券之星消息,根据12月10日市场公开信息、上市公司公告及交易所披露数据整理,奥精医疗最新董监高及相关人员股份变动情况:2025年12月10日公司董事仇志烨、董事宋天喜共减持公司股份2.0万股,占公司总股本为0.0146%。变动期间公司股价下跌1.13%,12月10日当日收盘报20.04元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000035588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688613"],"gpt_icon":0},{"id":"2590034373","title":"奥精医疗:12月9日高管仇志烨、宋天喜、王玲减持股份合计1.7万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2590034373","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590034373?lang=zh_cn&edition=full","pubTime":"2025-12-09 20:01","pubTimestamp":1765281704,"startTime":"0","endTime":"0","summary":"证券之星消息,根据12月9日市场公开信息、上市公司公告及交易所披露数据整理,奥精医疗最新董监高及相关人员股份变动情况:2025年12月9日公司董事仇志烨、董事宋天喜、高级管理人员王玲共减持公司股份1.7万股,占公司总股本为0.0124%。变动期间公司股价上涨3.21%,12月9日当日收盘报20.27元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900035040.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688613","BK0251"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770548927005,"stockEarnings":[{"period":"1week","weight":-0.0233},{"period":"1month","weight":0.0306},{"period":"3month","weight":-0.0018},{"period":"6month","weight":0.0987},{"period":"1year","weight":0.3532},{"period":"ytd","weight":0.096}],"compareEarnings":[{"period":"1week","weight":-0.0127},{"period":"1month","weight":-0.0049},{"period":"3month","weight":0.017},{"period":"6month","weight":0.1184},{"period":"1year","weight":0.243},{"period":"ytd","weight":0.0244}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"奥精医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"9862人(较上一季度增加15.44%)","perCapita":"13892股","listingDate":"2021-05-21","address":"北京市海淀区开拓路5号3层A305","registeredCapital":"13700万元","survey":" 奥精医疗科技股份有限公司的主营业务是高端生物医用材料及相关医疗器械产品的研发、生产、销售及服务。公司的主要产品是BONGOLD、单牙抗旋基台、骼金、齿贝、颅瑞、口腔种植体。公司先后承担了国家“863计划”重大项目课题、“十一五”和“十二五”国家科技支撑计划、“十三五”和“十四五”国家重点研发计划、山东省重点研发计划(重大科技创新工程)项目、北京市科技计划等国家和省部级重大研发项目,并荣获国家级和北京市专精特新“小巨人”企业、国家高新技术企业、北京市企业技术中心、北京生物医药产业跨越发展工程(G20工程)-创新引领企业、北京市海淀园“海帆企业”、北京市级企业科技研究开发机构等荣誉和资质,并在北京和山东两地均拥有院士工作站。公司的矿化胶原人工骨修复产品被中国科技部评为“国际原创类创新医疗器械”,材料的相关基础研究和产业化工作曾荣获国家自然科学奖二等奖、国家技术发明奖二等奖,产品的临床应用和治疗体系研究荣获北京市科学技术进步奖二等奖和中华医学会医学科学技术奖一等奖,产品的创新研究荣获第48届日内瓦国际发明展金奖。报告期内,由解放军总医院第四医学中心骨科医学部王征教授团队牵头、奥精医疗科技股份有限公司深度参与的国家级科研项目“脊柱脊髓战创伤救治技术创新与应用”,凭借其突破性成果和重大军事应用价值荣获中央军委颁发的军事科学技术进步奖一等奖。","listedPrice":16.43},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奥精医疗(688613)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奥精医疗(688613)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奥精医疗,688613,奥精医疗股票,奥精医疗股票老虎,奥精医疗股票老虎国际,奥精医疗行情,奥精医疗股票行情,奥精医疗股价,奥精医疗股市,奥精医疗股票价格,奥精医疗股票交易,奥精医疗股票购买,奥精医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奥精医疗(688613)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奥精医疗(688613)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}